...
首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Associations between phosphate binders prescription, illness perception, and depression in hemodialysis patients
【24h】

Associations between phosphate binders prescription, illness perception, and depression in hemodialysis patients

机译:血液透析患者中​​磷酸盐结合剂处方,疾病感知和抑郁之间的关联

获取原文
           

摘要

Studies among hemodialysis (HD) patients have looked into relationships between illness perception (IP), depression, and adherence yet rarely looked further into medication factors. Those studies were also conducted at urban HD centers leaving out those from a smaller town. Our objective is to determine phosphate binders (PBs) influences on IP and depression among HD population in smaller town. One hundred and thirteen patients from three Central Pahang Cluster Hospitals, Malaysia on HD were interviewed using Malay version of the Brief IP Questionnaire and Beck Depression Inventory II (BDI-II). This study found a significant positive correlation between PBs daily dose frequency with consequence, timeline, and illness concern. Type of PBs used influenced personal control significantly. History of PBs side effects resulted in significantly lower treatment control and lower emotional representation. There was a significant negative relationship between dialysis vintage with both identity and IP score. Depressed patients had significantly higher emotional representation compared to healthy controls. Meanwhile, there was a positive correlation between BDI-II score with coherence, consequence, and emotional representation. Around 23.9% of the patients reported symptoms of depression. Depressed patients had significantly shorter dialysis vintage compared to healthy controls. They tended to report a significant history of hospital admission in the past six months that peaked among those on HD between four to six years. The current study showed the effect of PBs therapy on IP while depression was associated with HD duration and hospital admission. This information can be used to formulate a better treatment approach by health-care practitioners toward better patients treatment hence outcomes.
机译:血液透析(HD)患者的研究已经研究了疾病知觉(IP),抑郁和依从性之间的关系,但很少深入研究药物因素。这些研究也在城市高清中心进行,而忽略了一个较小城镇的研究。我们的目标是确定磷酸盐粘合剂(PBs)对小城镇高清人口的IP和抑郁症的影响。使用马来文摘要IP问卷和贝克抑郁量表II(BDI-II)对来自马来西亚三家中央彭亨州立医院的113位患者进行了高清访谈。这项研究发现,PBs日剂量频率与后果,时间表和疾病问题之间存在显着的正相关。使用的PB的类型对个人控制有很大影响。 PB的副作用史导致治疗控制明显降低,情绪表征降低。透析时间与身份和IP评分之间存在显着的负相关关系。与健康对照组相比,抑郁症患者的情绪表征明显更高。同时,BDI-II评分与连贯性,结果和情感表达之间存在正相关。大约23.9%的患者报告有抑郁症状。与健康对照组相比,抑郁症患者的透析时间明显缩短。他们倾向于报告过去六个月住院的重要历史,而在HD病房中则介于四到六年之间。当前的研究表明,PBs治疗对IP的影响,而抑郁症与HD持续时间和住院次数有关。该信息可用于由医疗保健从业者制定更好的治疗方法,从而为患者提供更好的治疗,从而取得更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号